Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Drugs that activate the GLP-1 receptor are available on the market as treatments for T2DM or obesity
Your payment also begins building your surgery credit balance
Diabetes Obes Metab 14(12):10881096 Sloan-Lancaster J, Abu-Raddad E, Polzer J, Miller JW, Scherer JC, De Gaetano A et al (2013) Double-blind, randomized study evaluating the glycemic and anti-inflammatory effects of subcutaneous LY2189102, a neutralizing IL-1beta antibody, in patients with type 2 diabetes
Commercial insurance : Most major insurers now cover FDA-approved GLP-1 weight-loss medications (Wegovy, Saxenda, Zepbound) with prior authorization
Front Nutr 10:1183899 Wharton S et al (2019) Liraglutide 3.0 mg for the management of insufficient weight loss or excessive weight regain post-bariatric surgery
Reach Out
US$ 29.41
US$ 29.06
)
US$ 24.06
US$ 28.36
